Download Citation
Article Source:
Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy
Krueger J,
Santinon F,
Kazanova A,
Issa ME,
Larrivee B,
et al.
(2021)
Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.
PLOS ONE 16(6): e0251731.
https://doi.org/10.1371/journal.pone.0251731